THERAPEUTIC FOCUS – Perspectives on Sigma-2 Modulation as a Therapeutic Modality for Slowing Age-Related Degenerative Disease
Drug Development & Delivery,
INTRODUCTION The senior population in the US is expected to grow from 46 million today to 95 million by 2060.1 This…